By: Amy Abernethy, M.D., Principal Deputy Commissioner, Kaveeta Vasisht, M.D., Pharm.D., Acting Associate Commissioner for Womens Health, Office of Womens Health, and, CAPT Terri L. Cornelison, M.D., Ph.D., Chief Medical Officer and Director, Health of Women Program, Center for Devices and Radiological Health
For the past 25 years, the U.S. Food and Drug Administration's Office of Womens Health has forged a pathway fostering and supporting advancements in the health of women through its work across the agency and with stakeholders. Developments in science have advanced our understanding of the unique role that sex and gender play in health and disease. Sex refers to an individuals biological characteristics, stemming from chromosomal complement. Alternatively, gender refers to the social construct by which we define ourselves as woman, man or other.
The Office of Womens Health (the Office) was established in 1994 and throughout its history has protected and advanced the health of women through science, policy, education, and outreach, and has advocated for the inclusion of women in clinical trials. The Office achieves our mission through the foundational principle that Sex as a Biological Variable should be factored into research design, analysis, reporting, and education. Our work in womens health also reminds us that issues pertinent to women are relevant to many others.
The Office of Womens Health has led workshops and collaborated with other agencies, industry, professional associations, and advocacy groups to address issues that are critically important to the health of women. The Office has provided nearly $40 million in research funding supporting more than 380 womens health projects, including research on cancer, HIV, osteoporosis, and the number one killer of women, cardiovascular disease. In addition, the Office brings world renowned speakers to provide educational seminars to FDA staff on the importance of sex and gender considerations in regulatory science.
The Office of Womens Health also works to promote and secure the inclusion of women in clinical trials and identifies and monitors the progress of crosscutting and multidisciplinary womens health initiatives. Those initiatives include emerging public health issues that require additional study, including, for example, how sex and gender influence opioid and nicotine use.
Last year, in collaboration with the FDA's Center for Drug Evaluation and Research and itsCenter for Tobacco Products, the Office of Womens Health hosted a 2-day public meeting, Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender. This meeting addressed these important issues and spotlighted the influences of sex and gender that lead men and women to initiate and experience substance use disorders differently. The Office has published the conference proceedings and is funding research to better understand the public health impact of sex differences on the genetics of smoking-related illness.
The FDAs Office of the Commissioner recently designated the Office of Womens Health to serve on the Task Force on Research Specific to Pregnant and Lactating Women. Established in 2016 by the 21st Century Cures Act, the Task Force advises the Secretary of Health and Human Services (HHS) about gaps in knowledge and research on safe and effective therapies for pregnant and lactating women. In September 2018, the Task Force submitted its report and 15 recommendations to HHS and Congress. Because of its work, the Task Force was extended for another two years and the Office of Womens Health continues to provide leadership and guidance to the Task Force on the implementation of these recommendations.
To help guide ourwork in the many areas that affect womens health, the Office of Womens Health created the Womens Health Research Roadmap, which highlights research priority areas, including: advancing safety and efficacy of FDA-regulated products; improving clinical study design and analyses; using novel modeling and simulation approaches; advancing biomarker science; expanding data sources and analysis; improving health communications; and, using emerging technologies to support identification of sex differences.
To help measure the impact and outcomes of programmatic initiatives, the Office developed the Research Impact and Outcomes Framework, a first-of-its kind, metric-driven framework, whichenables the Office to evaluate research on conditions that affect women disproportionately, as well as studies on sex differences that impact the use of FDA-approved, cleared, or market authorized products. The Research Impact and Outcome Framework is used prospectively to evaluate research proposals under consideration for funding by the Office based on how well the research aligns with the Offices mission and research priorities. The frameworks retrospective metrics are used to evaluate and assign value to a projects impact on womens health from a regulatory perspective, to help the Office of Womens Health identify gaps in its research portfolio, and to help the Office determine future funding priorities.
In 2019, the Office of Womens Health funded research projects on pulmonary embolism, which is the blockage of blood flow to the lungs by blood clots, and a leading cause of maternal death,and the development of an artificially-intelligent virtual pregnant woman modeling suite to support regulatory decisions. Funding was also allocated to evaluate the labeling compliance of dietary supplements targeted specifically to women, as well as evaluation of potential contamination of products that contain live microbes, with special emphasis on pregnant women and lactating women, and infants.
The Office is also providing funding for malaria research, utilizing model-informed drug development to facilitate antimalaria dosing in pregnant women. Other research funded in 2019 includes research to address patient reported outcomes during breast cancer drug development, evaluating the clinical comparability of U.S. vs. non-U.S. clinical trial data for FDA-regulated medical devices for weight-loss treatment, and funding for research on the use of computational models to evaluate the safety and effectiveness of vaginal heat therapy devices.
Take Time to Care is one of the Office of Womens Health first public education programs. It is a multi-faceted program that disseminates FDA health education materials through outreach activities and collaborative partnerships with national womens health and health professional organizations, community and faith-based institutions, industry, universities, and other government agencies. Utilizing this outreach collaboration model, the Office of Womens Health developed and continues to implement national outreach campaigns, including such initiatives as the Diverse Women in Clinical Trials, the Use Medicines Wisely Campaign, the Pink Ribbon Sunday Mammography Awareness Initiative, and, the College Womens Health Campaign.
Ensuring women have access to safe medical products on the market and that these products meet their health care needs are top priorities for the FDA. In 2019, the FDAs Center for Drug Evaluation and Research (CDER) approved a variety of new therapies to help advance womens health. Notably, CDER approved a new targeted therapy for patients with a certain type of metastatic breast cancer, a new biologic drug to treat osteoporosis in certain postmenopausal women at high risk of breaking a bone, a new drug to treat premenopausal women with acquired, generalized hypoactive sexual desire disorder (low sexual desire), and the first FDA-approved drug specifically for the treatment of adult women with postpartum depression.
The FDAs Center for Devices and Radiological Health (CDRH) also recognizes that sex and gender may have considerable impact on health, and on interaction with medical devices. As we learn more about sex- and gender-based differences in the performance of medical devices and new innovations become a reality, we work to ensure that our policies continue to evolve with the current science.
In 2016, CDRH created its Health of Women Program to address the steadily growing importance of sex- and gender-specific issues that arise regarding medical technology design and development, clinical trial design, and other medical device-related matters.
In September, 2019, CDRH unveiled a new Health of Women Program Strategic Plan, and is seeking input from stakeholders to help shape its implementation. The CDRH Health of Women Program and its Strategic Plan extends beyond reproductive and gynecologic health. The approach is comprehensive it considers a womans entire body, including health conditions specific to women, conditions more common or more serious in women, distinct causes or manifestations in women, different outcomes or treatment options in women, and conditions with higher morbidity or mortality in women.
Through the Health of Women Program, CDRH researchers, reviewers, and analysts are considering how sex and gender are factored into research design, device development, and analyses of studies in humans, vertebrate animals, tissue cultures and primary cell lines.
This work being led by CDRH is an important step forward for the FDA. Along with other centers and offices across the FDA, it amplifies the Office of Womens Health foundational principle that considerations of sex and gender should be factored into research design, analysis, reporting and education.
The FDA takes very seriously its long-standing commitment and involvement in medical science and growth in our overall understanding of, and approach to, womens health. The absolute need for research, data, and insight that reflects the overall health of a woman and the foundational principle of Sex as a Biological Variable remains at the forefront of the work we do agency-wide in carrying out our mission to protect and promote public health.
FDA actions to protect womens health over the past quarter century are memorialized in the FDAs History Vault. Whether through accelerating an approval, removing a product from the market, or by issuing guidance on nutrition and dietary supplements, the FDA has used its regulatory authorities to advance womens health.
In honor of the 25th anniversary of the Office of Womens Health, the FDA History Office has created an exhibit highlighting the agencys long-standing commitment to protecting and promoting womens health. These historical artifacts and images are currently on display at the FDAs White Oak Campus in Silver Spring, Maryland, and can also be viewed remotely on FLICKR.
- Deep01 Closes Fundraising Led by ASUS and Received the First Purchase Order of Their AI-Based Medical Device in Taiwan - PRNewswire - June 24th, 2020
- Vacuum Cupping Market Comprehensive Insights 2020 to 2026: Kangzhu, Hwato, BeiJing GuoYiYan Medical Technology and Medical Instrument CO., LTD - Cole... - June 24th, 2020
- World Market for Medical Sensors to 2027 and the Impact of Covid-19 - GlobeNewswire - June 24th, 2020
- Laidlaw Venture Partners Continues Strategic Growth with Addition of Jeff Conroy and George Serafin to its Board of Advisors - cnweekly - June 24th, 2020
- How Adopting Factory of the Future Technology Will Help in Medical... - Medical Tech Outlook - June 24th, 2020
- N95 Face Masks Get Pathogen Killing Technology with Addition of New UVC Medical Device - HospiMedica - June 24th, 2020
- This New App Analyzes Your Voice Quality To Diagnose Congestive Heart Failure: Can It Help With Covid-19? - Forbes - June 24th, 2020
- Hospital Furnitures Market | Covid-19 Impact | Demand, Cost Structures, Latest trends, and Forecasts to 2026 | Stryker, Bio Medical Solutions, GPC... - June 24th, 2020
- Securing best distributor is key to commercialisation in the medical field - Small Caps - June 24th, 2020
- MWE receives 1.45m loan to help fight COVID-19 - Med-Tech Innovation - June 24th, 2020
- Immigration Advice Service: the limits of technology in healthcare - Health Europa - June 24th, 2020
- Capillary Blood Collection Devices Market to See Booming Ahead | Global Players are Radiometer Medical ApS, Sarstedt AG & Co, Becton, Dickinson... - June 24th, 2020
- Spine Biologics Market 2020: Challenges, Growth, Types, Applications, Revenue, Insights, Growth Analysis, Competitive Landscape, Forecast- 2025 - Cole... - June 24th, 2020
- Biocept reaches deal to cover out-of-network patients for its liquid biopsy tests - Proactive Investors USA & Canada - June 24th, 2020
- Global Medical Device Software Testing Services Market 2020: Which technology is expected to trend higher? - 3rd Watch News - June 24th, 2020
- Global Medical Imaging Information System Market 2020 Trends, Industry Size, Share, Technology Demand, Growth Drivers and 2026 Forecast Overview -... - June 24th, 2020
- Securing Medical Technology in the Age of COVID-19 - Infosecurity Magazine - June 5th, 2020
- Lumenis MOSES Technology Wins 2020 MedTech Breakthrough Award for Innovation in Surgical Technology - Yahoo Finance - June 5th, 2020
- BioSig Technologies's PURE EP System to be Presented in Heart Rhythm Society 2020 Science Sessions - GlobeNewswire - June 5th, 2020
- The European Medical Device market is projected to grow at a CAGR of 4.7 % between 2020 and 2025. - PRNewswire - June 5th, 2020
- Do OTAs need more regulation? - Washington Technology - June 5th, 2020
- Neuronetics to Present at the William Blair 40th Annual Growth Stock Conference - GlobeNewswire - June 5th, 2020
- 2020 Assessment of the Infectious Diseases Diagnostics Market and Impact of COVID-19 - Growing Number of COVID-19 Tests, Rise in Adoption of AI in... - June 5th, 2020
- Medical Central Gas Station Market Global Insights and Trends to 2026 | Medicoengineering doo, zmc Medical Devices and Medical Gas Systems, INSPITAL... - June 5th, 2020
- Rockford Psychiatric Medical Services provides positive feedback on the use of Nexstim NBT system with theta burst protocol for treatment of... - June 5th, 2020
- Impact of Corona on Medical Ceramics Market : How much will be the total production? - Cole of Duty - June 5th, 2020
- Digital Health Market is Likely to Exhibit Significant CAGR; Rising Popularity of Real-time Solutions will Promote Growth says Fortune Business... - June 5th, 2020
- Lakehead researchers teaming with high-tech firm on medical scheduling software - Northern Ontario Business - June 5th, 2020
- Soft Tissue Market: In-Depth Industry Analysis and Trends Analysis till 2030 - Cole of Duty - June 5th, 2020
- Bioresorbable Scaffold Market 2020 | Know the Latest COVID19 Impact Analysis And Strategies of Key Players: L-3 Communications Holdings, Inc., Hr... - June 5th, 2020
- Top 5 Major End User industries will boost the growth of Smart Pills Technology Market - Cole of Duty - June 5th, 2020
- Medical Tourism Market 2020 Latest Trending Technology, Growing Demand, Application, Types, Services, Regional Analysis and Forecast to 2025 - Cole of... - June 5th, 2020
- Hysteroscopic Endometrial Resection Procedures Market Trends Analysis, Top Manufacturers, Shares, Growth Opportunities, Statistics & Forecast to... - June 5th, 2020
- Amid the COVID-19 crisis and the looming economic recession, the Mannequin-Based Simulation market worldwide will grow by a projected US$3.7 Billion,... - June 5th, 2020
- The Ten Hottest Medical Technologies in 2019 - May 13th, 2020
- Technology engineered at ASU 50 years ago helps battle COVID-19 - ASU Now - May 13th, 2020
- Enhancing recovery: the rise of medical technology in sport - Medical Device Network - May 13th, 2020
- U.S. Officials: Beware Of China And Others Trying To Steal COVID-19 Research - NPR - May 13th, 2020
- How is the pandemic changing investments in HR tech? - Human Resource Executive - May 13th, 2020
- Global Hospital Beds Market (2020 to 2025) - Outlook and Forecast - ResearchAndMarkets.com - Business Wire - May 13th, 2020
- Safe Orthopaedics Announces the Registration of Several Trademarks in Japan - OrthoSpineNews - May 13th, 2020
- Brian Wagner: We need leadership to protect us - Loveland Reporter-Herald - May 13th, 2020
- Scientists are racing to design a face mask that can rip coronavirus apart - Fast Company - May 13th, 2020
- Medical Disinfection and Sterilization Equipment Market Valuation 2020 | Key Trends, Growth Drivers, In Depth Analysis, Solution and Businesss... - May 13th, 2020
- Medical Perfusion Technology Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026 - 3rd Watch News - May 13th, 2020
- The U.S. Army Wants Wearable Tech That Detects the Coronavirus - Popular Mechanics - May 13th, 2020
- Global Medical Rollator Walker Market 2020 Business Outlook with COVID-19 Scenario | Drive DeVilbiss Healthcare, Kaiyang Medical Technology, TOPRO -... - May 13th, 2020
- Gynecological Examination Tables Market Analysis and Demand with Forecast Overview to 2026 - Cole of Duty - May 13th, 2020
- Global Medical Technologies (GMT) at the Forefront of Healthcare Innovations in the Philippines - MB TechNews - May 13th, 2020
- Virtual care in the age of COVID-19 and beyond - Health Europa - May 13th, 2020
- Interdisciplinary research study uses VR Technology to assess interprofessional communication in healthcare education - Nevada Today - May 9th, 2020
- 5 Reasons Why Vapotherm Will Keep Climbing - The Motley Fool - May 9th, 2020
- Biosense Webster Unveils Late-Breaking Results from PRECEPT Study in Patients with Persistent Atrial Fibrillation - BioSpace - May 9th, 2020
- Needle-Free Drug Delivery Devices Market 2020, Booms the Global Industry Growth at Impressive CAGR Over Forecast Period and Dominated by Key... - May 9th, 2020
- COVID-19 pushes healthcare technology transformation in Asia - ASEAN TODAY - May 9th, 2020
- Vancouver theatre being used as space to help create new medical equipment | Venture - Daily Hive - May 9th, 2020
- The Potential Impact of Coronavirus (COVID-19) for Advent of Disruptive Technologies to Support the Growth of the ENT Diagnostic Devices Market During... - May 9th, 2020
- St. Luke's medical technology lab pivots to coronavirus response - The Gazette: Eastern Iowa Breaking News and Headlines - May 8th, 2020
- Tech experts: Widespread adoption of telemedicine, remote monitoring 'here to stay' - FierceHealthcare - May 8th, 2020
- Safe Orthopaedics enters into exclusive negotiations for the acquisition of LCI Medical - OrthoSpineNews - May 8th, 2020
- Wi-Fi at the Nightingale, virtual GP at carehomes, and new technologies related to COVID-19 - MobiHealthNews - May 8th, 2020
- New Data Unveiled at Heart Rhythm 2020 Demonstrate Effectiveness of App-Based Remote Monitoring of Medtronic Cardiac Devices, Significant Reduction in... - May 8th, 2020
- Camber Spine Technologies Announces Nationwide Launch of SPIRA-C Integrated and FORTICO Anterior Cervical Plate - OrthoSpineNews - May 8th, 2020
- The Benefits of Tech Even Those That Don't Cut Costs - The Tech Report - May 8th, 2020
- Pro Medicus: Healthcare IT Developer With Impressive Growth Story - Seeking Alpha - May 8th, 2020
- Michael Schmertzler Joins the Board of ViralClear Pharmaceuticals, a Majority-Owned Subsidiary of BioSig Technologies, Inc. - GlobeNewswire - May 8th, 2020
- Global Disposable Glove Market Insights (2020 to 2025) - Analysis and Forecasts by Manufacturers, Regions, Technology, Application & Product Type... - May 8th, 2020
- Heated Breathing Circuits Market Size, Analytical Overview, Growth Factors, Demand, Trends and Forecast to 2026 | Teleflex Incorporated, Armstrong... - May 8th, 2020
- Latest Research on Hospital Furnitures Market 2020 by Application, Industry Share, End User with top players Stryker, Bio Medical Solutions, GPC... - May 8th, 2020
- Huge Growth Excepted in Cystometry Catheters Market in Upcoming Years Complete Analysis by 2020-2027 Profiling Top Key Players Amecath, Andromeda,... - May 8th, 2020
- It is impossible to get out of stock! The production speed of masks is far beyond your imagination! - ADOTAS - May 8th, 2020
- Fiagon partners with Smith+Nephew to distribute its ENT surgical navigation portfolio in the Asia Pacific region - BioSpace - May 6th, 2020
- AdvaMed launches platform to help scale the production and distribution of ventilators - Medical Plastics News - May 6th, 2020
- AdvaMed Announces VentConnect Online Platform to Scale the Production and Distribution of Ventilators - Business Wire - May 6th, 2020
- What is driving the Interventional Fluoroscopy Systems? Market size? Key players are EMD Medical Technologies, GE Healthcare, Lepu Medical Technology,... - May 6th, 2020
- Outlook on the Worldwide Sleep Apnea Therapeutic & Diagnostic Devices Industry to 2024 - Insights & Forecast with Potential Impact of COVID-19... - May 6th, 2020
- Orthopedic Surgery Instrument Market 2020 Latest Innovations, Trends, Growth Factors and Opportunities by 2026 | Orthofix, Wright Medical Technology,... - May 6th, 2020
- Transcutaneous Bilirubinometer Market 2020 Economic Impact and Future Prospects | Aegis Medical Innovations, Delta Medical International, Drgerwerk... - May 6th, 2020
- U.S. Arms Makers and Medical Device Firms Team Up to Make Ventilators - The New York Times - May 6th, 2020
- Biotech and Investment Veteran Dennis Purcell Joins the Board of ViralClear Pharmaceuticals, a majority-owned subsidiary of BioSig Technologies, Inc.... - May 6th, 2020